Share on StockTwits

ZS Pharma (NASDAQ:ZSPH) shares hit a new 52-week high during trading on Thursday , AR Network reports. The company traded as high as $36.10 and last traded at $35.35, with a volume of 55,924 shares trading hands. The stock had previously closed at $33.74.

Several analysts have recently commented on the stock. Analysts at Credit Suisse initiated coverage on shares of ZS Pharma in a research note on Monday, July 14th. They set an “outperform” rating and a $51.00 price target on the stock. Separately, analysts at William Blair initiated coverage on shares of ZS Pharma in a research note on Monday, July 14th. They set an “outperform” rating and a $75.00 price target on the stock. Finally, analysts at JPMorgan Chase & Co. initiated coverage on shares of ZS Pharma in a research note on Monday, July 14th. They set an “overweight” rating and a $43.00 price target on the stock.

The stock has a 50-day moving average of $29.11 and a 200-day moving average of $28.96. The company’s market cap is $719.9 million.

ZS Pharma (NASDAQ:ZSPH) last issued its quarterly earnings data on Thursday, August 14th. The company reported ($4.72) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.66) by $4.06. On average, analysts predict that ZS Pharma will post $-3.48 earnings per share for the current fiscal year.

ZS Pharma, Inc is a biopharmaceutical company focused on the development and commercialization of selective, non-absorbed drugs to treat renal, cardiovascular, liver and metabolic diseases.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.